Paper549190
Antibiotic-associated colitis: effects of antibiotics on Clostridium difficile and the disease in hamsters.
Fekety R and 7 others. Rev Infect Dis, 1979. Cited by 133 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Antibiotic-associated colitis: effects of antibiotics on Clostridium difficile and the disease in hamsters. Papers, record 549190. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/549190
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antibiotic-associated colitis: effects of antibiotics on Clostridium difficile and the disease in hamsters.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Clindamycin | Major topic |
| Clostridium | Major topic |
| Enterocolitis, Pseudomembranous | Major topic |
| Rodent Diseases | Major topic |
| Animals | |
| Clostridium Infections | |
| Cricetinae | |
| Disease Models, Animal | |
| Male | |
| Mesocricetus | |
| Microbial Sensitivity Tests | |
| Vancomycin |
Source PubMed
Cited by41
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 133 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,950,004 | Impact of empiric antibiotics on risk of Clostridioides difficile-a causal inference observational analysis. | Antimicrob Steward Healthc Epidemiol | 2025 | https://conductscience.org/library/papers/39950004 | PubMed |
| 39,912,651 | Clostridioides difficile infection study models and prospectives for probing the microbe-host interface. | J Bacteriol | 2025 | https://conductscience.org/library/papers/39912651 | PubMed |
| 39,276,186 | The 3 Ds: Depression, Dysbiosis, and Clostridiodes difficile. | Adv Ther | 2024 | https://conductscience.org/library/papers/39276186 | PubMed |
| 37,622,034 | Comparison of Different Antibiotics and the Risk for Community-Associated Clostridioides difficile Infection: A Case-Control Study. | Open Forum Infect Dis | 2023 | https://conductscience.org/library/papers/37622034 | PubMed |
| 36,794,831 | Mouse models for bacterial enteropathogen infections: insights into the role of colonization resistance. | Gut Microbes | 2023 | https://conductscience.org/library/papers/36794831 | PubMed |
| 29,950,381 | Clostridium difficile Alters the Structure and Metabolism of Distinct Cecal Microbiomes during Initial Infection To Promote Sustained Colonization. | mSphere | 2018 | https://conductscience.org/library/papers/29950381 | PubMed |
| 26,488,281 | Interactions Between the Gastrointestinal Microbiome and Clostridium difficile. | Annu Rev Microbiol | 2015 | https://conductscience.org/library/papers/26488281 | PubMed |
| 26,461,425 | The non-toxigenic Clostridium difficile CD37 protects mice against infection with a BI/NAP1/027 type of C. difficile strain. | Anaerobe | 2015 | https://conductscience.org/library/papers/26461425 | PubMed |
| 25,493,020 | Clostridium difficile infection aggravates colitis in interleukin 10-deficient mice. | World J Gastroenterol | 2014 | https://conductscience.org/library/papers/25493020 | PubMed |
| 24,335,555 | Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection. | Gut Microbes | 2014 | https://conductscience.org/library/papers/24335555 | PubMed |
| 24,076,318 | Murine models to study Clostridium difficile infection and transmission. | Anaerobe | 2013 | https://conductscience.org/library/papers/24076318 | PubMed |
| 24,040,011 | Muricholic acids inhibit Clostridium difficile spore germination and growth. | PLoS One | 2013 | https://conductscience.org/library/papers/24040011 | PubMed |
| 23,545,305 | Toll-like receptor 5-dependent immunogenicity and protective efficacy of a recombinant fusion protein vaccine containing the nontoxic domains of Clostridium difficile toxins A and B and Salmonella enterica serovar typhimurium flagellin in a mouse model of Clostridium difficile disease. | Infect Immun | 2013 | https://conductscience.org/library/papers/23545305 | PubMed |
| 22,595,318 | Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance. | Trends Microbiol | 2012 | https://conductscience.org/library/papers/22595318 | PubMed |
| 22,555,466 | Models for the study of Clostridium difficile infection. | Gut Microbes | 2012 | https://conductscience.org/library/papers/22555466 | PubMed |
| 22,198,617 | Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains. | Gut Microbes | 2011 | https://conductscience.org/library/papers/22198617 | PubMed |
| 22,069,662 | The enterotoxicity of Clostridium difficile toxins. | Toxins (Basel) | 2010 | https://conductscience.org/library/papers/22069662 | PubMed |
| 21,576,341 | Mouse relapse model of Clostridium difficile infection. | Infect Immun | 2011 | https://conductscience.org/library/papers/21576341 | PubMed |
| 16,048,976 | Effect of antibiotic treatment on growth of and toxin production by Clostridium difficile in the cecal contents of mice. | Antimicrob Agents Chemother | 2005 | https://conductscience.org/library/papers/16048976 | PubMed |
| 10,952,564 | In vitro and in vivo activities of nitazoxanide against Clostridium difficile. | Antimicrob Agents Chemother | 2000 | https://conductscience.org/library/papers/10952564 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/549190
GET https://conductscience.org/api/papers/v1/549190/cited_by?page=2